In several malignancies, an inverse correlation between EphB6 expression and solid tumor aggressiveness was observed; these include melanoma [47], neuroblastoma [48,49], colorectal [50] and prostate [51] cancers, thereby suggesting that EphB6 is capable of suppressing invasive and metastatic phenotypes [52]. This evidence concerns the gene EPHB6 and cancer.